Unrecognized Tax Benefits of Quince Therapeutics, Inc. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Quince Therapeutics, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • Quince Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2024 was $4,430,000, a 2.1% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Quince Therapeutics, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $4,430,000 +$91,000 +2.1% 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q4 2023 $4,339,000 +$651,000 +18% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q4 2022 $3,688,000 +$439,000 +14% 31 Dec 2022 10-K 24 Mar 2025 2024 FY
Q4 2021 $3,249,000 +$1,273,000 +64% 31 Dec 2021 10-K 01 Apr 2024 2023 FY
Q4 2020 $1,976,000 +$917,000 +87% 31 Dec 2020 10-K 15 Mar 2023 2022 FY
Q4 2019 $1,059,000 +$703,000 +197% 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q4 2018 $356,000 +$185,000 +108% 31 Dec 2018 10-K 01 Mar 2022 2021 FY
Q4 2017 $171,000 31 Dec 2017 10-K 01 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.